33,265 reports of this reaction
21.7% of all HYDROCODONE BITARTRATE AND ACETAMINOPHEN reports
#1 most reported adverse reaction
DRUG DEPENDENCE is the #1 most commonly reported adverse reaction for HYDROCODONE BITARTRATE AND ACETAMINOPHEN, manufactured by Amneal Pharmaceuticals LLC. There are 33,265 FDA adverse event reports linking HYDROCODONE BITARTRATE AND ACETAMINOPHEN to DRUG DEPENDENCE. This represents approximately 21.7% of all 153,212 adverse event reports for this drug.
Patients taking HYDROCODONE BITARTRATE AND ACETAMINOPHEN who experience drug dependence should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG DEPENDENCE is a frequently reported adverse event for HYDROCODONE BITARTRATE AND ACETAMINOPHEN, accounting for a significant proportion of all reports.
In addition to drug dependence, the following adverse reactions have been reported for HYDROCODONE BITARTRATE AND ACETAMINOPHEN:
The following drugs have also been linked to drug dependence in FDA adverse event reports:
DRUG DEPENDENCE has been reported as an adverse event in 33,265 FDA reports for HYDROCODONE BITARTRATE AND ACETAMINOPHEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG DEPENDENCE accounts for approximately 21.7% of all adverse event reports for HYDROCODONE BITARTRATE AND ACETAMINOPHEN, making it one of the most commonly reported side effect.
If you experience drug dependence while taking HYDROCODONE BITARTRATE AND ACETAMINOPHEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.